Literature DB >> 35896006

Peer providers and linkage with buprenorphine care after hospitalization: A retrospective cohort study.

Helen E Jack1, Eric D Denisiuk2, Brett A Collins2, Dan Stephens2, Kendra L Blalock1, Jared W Klein1, Elenore P Bhatraju1, Joseph O Merrill1, Kevin A Hallgren3, Judith I Tsui1.   

Abstract

Background: People with opioid use disorder (OUD) are increasingly started on buprenorphine in the hospital, yet many patients do not attend outpatient buprenorphine care after discharge. Peer providers, people in recovery themselves, are a growing part of addiction care. We examine whether patients who received a low-intensity, peer-delivered intervention during hospitalization had a greater rate of linking with outpatient buprenorphine care relative to those not seen by a peer.
Methods: This was a retrospective cohort study of adults with OUD who were started on buprenorphine during hospitalization. The primary outcome was receipt of a buprenorphine prescription within 30 days of discharge. Secondary outcomes included attendance at a follow-up visit with a buprenorphine provider within 30 days and hospital readmission within 90 days. Modified Poisson regression analyses tested for differences in the rate ratios (RR) of each binary outcome for patients who were versus were not seen by a peer provider. Peer notes in the electronic health record were reviewed to characterize peer activities.
Results: 111 patients met the study inclusion criteria, 31.5% of whom saw a peer provider. 55.0% received a buprenorphine prescription within 30 days of hospital discharge. Patients with versus without peer provider encounters did not significantly differ in the rates of receiving a buprenorphine prescription (RR = 1.06, 95% CI: 0.74-1.51), hospital readmission (RR = 1.45, 95% CI: 0.80-2.64), or attendance at a buprenorphine follow-up visit (RR = 1.03, 95% CI: 0.68-1.57). Peers most often listened to or shared experiences with patients (68.6% of encounters) and helped facilitate medical care (60.0% of encounters). Conclusions: There were no differences in multiple measures of buprenorphine follow-up between patients who received this low-intensity peer intervention and those who did not. There is need to investigate what elements of peer provider programs contribute to patient outcomes and what outcomes should be assessed when evaluating peer programs.

Entities:  

Keywords:  Buprenorphine; discharge planning; opioid use disorder; peer support

Mesh:

Substances:

Year:  2022        PMID: 35896006      PMCID: PMC9586121          DOI: 10.1080/08897077.2022.2095078

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.984


  38 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  Rapid qualitative research methods during complex health emergencies: A systematic review of the literature.

Authors:  Ginger A Johnson; Cecilia Vindrola-Padros
Journal:  Soc Sci Med       Date:  2017-08-02       Impact factor: 4.634

3.  Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.

Authors:  Sarah E Wakeman; Marc R Larochelle; Omid Ameli; Christine E Chaisson; Jeffrey Thomas McPheeters; William H Crown; Francisca Azocar; Darshak M Sanghavi
Journal:  JAMA Netw Open       Date:  2020-02-05

4.  Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service.

Authors:  Courtney D Nordeck; Christopher Welsh; Robert P Schwartz; Shannon Gwin Mitchell; Art Cohen; Kevin E O'Grady; Jan Gryczynski
Journal:  Drug Alcohol Depend       Date:  2018-03-02       Impact factor: 4.492

5.  Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder : A Randomized Trial.

Authors:  Jan Gryczynski; Courtney D Nordeck; Christopher Welsh; Shannon G Mitchell; Kevin E O'Grady; Robert P Schwartz
Journal:  Ann Intern Med       Date:  2021-04-06       Impact factor: 25.391

6.  Association Between Buprenorphine for Opioid Use Disorder and Mortality Risk.

Authors:  Priyanka Vakkalanka; Brian C Lund; Stephan Arndt; William Field; Mary Charlton; Marcia M Ward; Ryan M Carnahan
Journal:  Am J Prev Med       Date:  2021-05-19       Impact factor: 5.043

7.  Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.

Authors:  Margo E Godersky; Andrew J Saxon; Joseph O Merrill; Jeffrey H Samet; Jane M Simoni; Judith I Tsui
Journal:  Addict Sci Clin Pract       Date:  2019-03-13

8.  Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017.

Authors:  Taeho Greg Rhee; Gail D'Onofrio; David A Fiellin
Journal:  JAMA Netw Open       Date:  2020-10-01

9.  Peer support workers as a bridge: a qualitative study exploring the role of peer support workers in the care of people who use drugs during and after hospitalization.

Authors:  Robin Lennox; Larkin Lamarche; Tim O'Shea
Journal:  Harm Reduct J       Date:  2021-02-16

Review 10.  Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.

Authors:  Alister Martin; Kelley Butler; Tyler Chavez; Andrew Herring; Sarah Wakeman; Bryan D Hayes; Ali Raja
Journal:  West J Emerg Med       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.